Rafael Romaguera
Latest contributions
Key principles of successful large bore vascular access and closure: TAVI and beyond
21 May 2025 – From EuroPCR 2025
This session explores suture-mediated vascular closure techniques, particularly for TAVI and large-bore venous access.
Through real-world clinical case, speakers highlight the value of ultrasound and CT imaging for precise puncture planning and complication avoidance.
Detailed steps for arterial closure with ProGlide device are provided, with technical...
Making treatment and management of complex PCIs easier with Cre8 EVO
17 May 2023 – From EuroPCR 2023
Maximize patient clinical outcomes in complex percutaneous coronary interventions (PCIs) by joining this session. Discover how accurate patient evaluation, advanced imaging/functional modalities, optimized procedures, and the Cre8 EVO device contribute to improved safety and efficacy, and review the challenges associated with DES implantation in complex PCIs.
Cre8 EVO: the "sweetest advancement" that a diabetic patient is waiting for
18 May 2022 – From EuroPCR 2022
Thanks to a mix between cases and live lectures and discussions, this EuroPCR 2022 session will enable you to review the challenges of a PCI and the one-year results of the SUGAR RCT in diabetes mellitus patients, and to understand how to maximise PCI outcomes, especially by using Cre8 EVO...
SUGAR: A Randomized Trial of Amphilimus-eluting Stents and Zotarolimus-eluting Stents in Patients With Diabetes
04 Nov 2021
TCT 2021: Luis Ortega Paz interviews Rafael Romaguera, principal investigator of the SUGAR trial. SUGAR is the first powered trial to compare new generation DES in patients with diabetes, and also the first to include a broad population of patients with diabetes (all-comers design). It was...
Author
Author
Empowering DES performance in complex patients to maximise efficacy and safety outcomes
20 May 2021 – From EuroPCR 2021
Watch this session presented by Marco Valgimigli, Istvan Ferenc Edes, Antonio Colombo, Rafael Romaguera, Gennaro Sardella and Pieter Stella in order to identify the key elements and actions to be considered to maximise complex PCI outcomes in diabetes mellitus and high bleeding risks patients, to understand how re-PCI impacts...
